Roche Nimblegen Inc.

Part of Foundation Medicine, Inc.

UEI
QF1UC7LVHM99
CAGE
Not on record
Primary NAICS
Not on record
SAM.gov registration
Expired

Company facts

Entity structure
Other
Corporate family

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract awards

Award Agency Obligated Awarded
Mutation mapping and resequencing HHSN272200900619P NIAID DEA OA Acquisitions (NIH) -$4,320
For payment only/covering order for ADB order NEN75611 (purchase order (263-MQ-610742) from FY-06 HHSN261201000306P National Cancer Institute (NIH) $15,000
TAS::75 0600::tascgs-map 385K ARR SER (item number 05224764001) HHSF223201010525P Food and Drug Administration $8,602
Small purchase data V691D90004 Veterans Integrated Service Network 22 (VHA) $3,078
Perform CGH on whole-genome arrays to identify copy number changes that segregate with disease traits in CMM families… HHSN261200900050P National Cancer Institute (NIH) $50,000

Latest 5 listed here. See the rest on GovTribe.

Grant awards

Award Agency Obligated Awarded
Large-scale selection of genomic loci R21HG004553 National Institutes of Health $204,000

Quick answers

Is Roche Nimblegen Inc. registered in SAM.gov?

Roche Nimblegen Inc.'s SAM.gov registration expired on December 9, 2013.

What is Roche Nimblegen Inc.'s most recent federal award?

Roche Nimblegen Inc.'s most recent federal contract award is Mutation mapping and resequencing (HHSN272200900619P), from NIAID DEA OA Acquisitions (NIH), on December 9, 2013.

On GovTribe

See Roche Nimblegen Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login